Nykredit A S acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 41,386 shares of the company's stock, valued at approximately $19,990,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust boosted its position in shares of Astera Labs by 74.5% in the second quarter. Parkside Financial Bank & Trust now owns 96 shares of the company's stock valued at $46,000 after acquiring an additional 41 shares during the period. Corient Private Wealth LP grew its stake in shares of Astera Labs by 69.9% in the second quarter. Corient Private Wealth LP now owns 21,689 shares of the company's stock worth $10,476,000 after acquiring an additional 8,922 shares during the last quarter. Brown Financial Advisors bought a new position in Astera Labs during the second quarter worth $217,000. HighTower Advisors LLC increased its position in Astera Labs by 5.0% during the second quarter. HighTower Advisors LLC now owns 10,129 shares of the company's stock worth $4,893,000 after acquiring an additional 478 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Astera Labs during the 2nd quarter valued at $5,206,000. Institutional investors own 60.47% of the company's stock.
Astera Labs Stock Performance
Shares of ALAB stock opened at $303.25 on Friday. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The stock has a market cap of $52.61 billion, a price-to-earnings ratio of 150.12 and a beta of 3.77. The firm has a fifty day moving average of $303.33 and a 200-day moving average of $265.40.
Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm's revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period last year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.
Analyst Ratings Changes
Several research firms have recently issued reports on ALAB. UBS Group restated a "neutral" rating and set a $425.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Roth Capital reiterated a "buy" rating and issued a $450.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Bank of America lifted their target price on Astera Labs from $240.00 to $450.00 and gave the stock a "neutral" rating in a research report on Tuesday, June 23rd. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Astera Labs in a report on Tuesday, August 18th. Finally, Zacks Research upgraded Astera Labs from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $348.33.
Check Out Our Latest Stock Analysis on ALAB
Insider Activity
In other Astera Labs news, General Counsel Philip Mazzara sold 6,801 shares of the firm's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares in the company, valued at $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total value of $2,804,599.02. Following the sale, the director directly owned 3,970 shares in the company, valued at $1,237,965.10. The trade was a 69.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 592,244 shares of company stock valued at $209,729,973. 10.40% of the stock is owned by company insiders.
Astera Labs Company Profile
(
Free Report)
Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.
The company's portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.
Further Reading
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.